153 related articles for article (PubMed ID: 27658478)
21. Modeling Continuous Prognostic Factors in Survival Analysis: Implications for Tumor Staging and Assessing Chemotherapy Effect in Osteosarcoma.
Cates JMM
Am J Surg Pathol; 2018 Apr; 42(4):485-491. PubMed ID: 29200101
[TBL] [Abstract][Full Text] [Related]
22. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
Wang Z; Cai H; Lin L; Tang M; Cai H
Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
[TBL] [Abstract][Full Text] [Related]
23. Age as a prognostic factor for patients with osteosarcoma: an analysis of 438 patients.
Harting MT; Lally KP; Andrassy RJ; Vaporciyan AA; Cox CS; Hayes-Jordan A; Blakely ML
J Cancer Res Clin Oncol; 2010 Apr; 136(4):561-70. PubMed ID: 19784847
[TBL] [Abstract][Full Text] [Related]
24. P16 expression predicts necrotic response among patients with osteosarcoma receiving neoadjuvant chemotherapy.
Borys D; Canter RJ; Hoch B; Martinez SR; Tamurian RM; Murphy B; Bishop JW; Horvai A
Hum Pathol; 2012 Nov; 43(11):1948-54. PubMed ID: 22578565
[TBL] [Abstract][Full Text] [Related]
25. Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup.
Hauben EI; Weeden S; Pringle J; Van Marck EA; Hogendoorn PC
Eur J Cancer; 2002 Jun; 38(9):1218-25. PubMed ID: 12044509
[TBL] [Abstract][Full Text] [Related]
26. The extremity localized classic osteosarcomas have better survival than the axial non-classics.
Lin L; Deng S; Zhang F; Liang Y; Huang Z
World J Surg Oncol; 2018 Feb; 16(1):39. PubMed ID: 29471883
[TBL] [Abstract][Full Text] [Related]
27. Pathological fractures in predicting clinical outcomes for patients with osteosarcoma.
Chung LH; Wu PK; Chen CF; Weng HK; Chen TH; Chen WM
BMC Musculoskelet Disord; 2016 Dec; 17(1):503. PubMed ID: 28031047
[TBL] [Abstract][Full Text] [Related]
28. Does expression of glucose transporter protein-1 relate to prognosis and angiogenesis in osteosarcoma?
Kubo T; Shimose S; Fujimori J; Furuta T; Arihiro K; Ochi M
Clin Orthop Relat Res; 2015 Jan; 473(1):305-10. PubMed ID: 25193692
[TBL] [Abstract][Full Text] [Related]
29. Can pretreatment
Song H; Jiao Y; Wei W; Ren X; Shen C; Qiu Z; Yang Q; Wang Q; Luo QY
Eur Radiol; 2019 Jul; 29(7):3945-3954. PubMed ID: 30859285
[TBL] [Abstract][Full Text] [Related]
30. Vascular endothelial growth factor expression in osteosarcoma.
Charity RM; Foukas AF; Deshmukh NS; Grimer RJ
Clin Orthop Relat Res; 2006 Jul; 448():193-8. PubMed ID: 16826116
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors and survival rate of osteosarcoma: A single-institution study.
Faisham WI; Mat Saad AZ; Alsaigh LN; Nor Azman MZ; Kamarul Imran M; Biswal BM; Bhavaraju VM; Salzihan MS; Hasnan J; Ezane AM; Ariffin N; Norsarwany M; Ziyadi MG; Wan Azman WS; Halim AS; Zulmi W
Asia Pac J Clin Oncol; 2017 Apr; 13(2):e104-e110. PubMed ID: 25870979
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant Chemotherapy Followed by Delayed Surgery: Is it Necessary for All Patients With Nonmetastatic High-Grade Pelvic Osteosarcoma?
Xu J; Xie L; Guo W
Clin Orthop Relat Res; 2018 Nov; 476(11):2177-2186. PubMed ID: 29912746
[TBL] [Abstract][Full Text] [Related]
33. Tumor volume change after chemotheraphy as a predictive factor of disease free survival for osteosarcoma.
Moon SH; Shin KH; Suh JS; Yang WI; Noh JK; Hahn SB
Yonsei Med J; 2005 Feb; 46(1):119-24. PubMed ID: 15744814
[TBL] [Abstract][Full Text] [Related]
34. Histologic response of high-grade nonmetastatic osteosarcoma of the extremity to chemotherapy,
Bacci G; Ferrari S; Bertoni F; Picci P; Bacchini P; Longhi A; Donati D; Forni C; Campanacci L; Campanacci M
Clin Orthop Relat Res; 2001 May; (386):186-96. PubMed ID: 11347833
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Value of Vascular Invasion in Pediatric Osteosarcomas.
Benezech S; Chabaud S; Chambon F; Dijoud F; Chotel F; Marec-Berard P
Pathol Oncol Res; 2016 Oct; 22(4):847-52. PubMed ID: 27230613
[TBL] [Abstract][Full Text] [Related]
36. Characterization of localized osteosarcoma of the extremity in children, adolescents, and young adults from a single institution in South Texas.
Sugalski AJ; Jiwani A; Ketchum NS; Cornell J; Williams R; Heim-Hall J; Hung JY; Langevin AM
J Pediatr Hematol Oncol; 2014 Aug; 36(6):e353-8. PubMed ID: 24487915
[TBL] [Abstract][Full Text] [Related]
37. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE
Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases.
Ward WG; Mikaelian K; Dorey F; Mirra JM; Sassoon A; Holmes EC; Eilber FR; Eckardt JJ
J Clin Oncol; 1994 Sep; 12(9):1849-58. PubMed ID: 8083708
[TBL] [Abstract][Full Text] [Related]
39. Histologic Response and Toxicity following Interval-Compressed Four-Drug Therapy Given Preoperatively in Children and Young Adults with Osteosarcoma: A Retrospective Study.
Kang JM; Ju HY; Joo J; Sung JY; Park SY; Kim JH; Kang HG; Kwon M; Park M; Park HJ; Park BK
Oncology; 2020; 98(2):81-90. PubMed ID: 31509843
[TBL] [Abstract][Full Text] [Related]
40. Is it important to maintain high-dose intensity chemotherapy in the treatment of adults with osteosarcoma?
Kushnir I; Kolander Y; Bickels J; Gortzak Y; Flusser G; Issakov J; Merimsky O
Med Oncol; 2014 May; 31(5):936. PubMed ID: 24719037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
